Prescription Drug, N.B. Reg. 84-170
Section 12.3
Cite as Prescription Drug, N.B. Reg. 84-170, s. 12.3 · current to September 15, 2026 · read from New Brunswick Acts and Regulations on November 16, 2026
The text
For the purposes of paragraph 2.11(1)(a) of the Act, the information is as follows:
(a) the drug name;
(b) the strength and the dosage form;
(c) the drug identification number;
(d) the name of the original product deemed equivalent to the applicant drug;
(e) the proposed drug price;
(f) the lowest price at which the drug is offered in another Canadian province or territory;
(g) whether the drug is the only available interchangeable pharmaceutical product deemed equivalent to the original product;
(h) whether the cost of producing and distributing the interchangeable pharmaceutical product exceeds the maximum allowable price; and
(i) if the cost of producing and distributing the interchangeable pharmaceutical product exceeds the maximum allowable price, the cost of the individual raw materials, the manufacture and the distribution, excluding rebates.
Read the Prescription Drug on the Province's website ↗
Made under Prescription Drug Payment Act, c. P-15.01.